Smart Nanocarriers for Controlled Release of Therapeutics in Inflammatory Diseases
Received Date: Jul 01, 2024 / Published Date: Jul 29, 2024
Abstract
Inflammatory diseases pose significant challenges in treatment due to their chronic nature and complex pathophysiology. Smart nanocarriers have emerged as promising platforms for delivering therapeutics with precision and efficacy. This article reviews the design principles, mechanisms, and recent advancements in smart nanocarriers for controlled release of therapeutics in inflammatory diseases. Key strategies for targeting inflamed tissues, modulating immune responses, and enhancing therapeutic outcomes are discussed, highlighting the transformative potential of nanotechnology in personalized medicine.
Citation: Toshimori B (2024) Smart Nanocarriers for Controlled Release of Therapeutics in Inflammatory Diseases. J Mol Pharm Org Process Res 12: 243.
Copyright: © 2024 Toshimori B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open 91桃色 Journals
Article Usage
- Total views: 437
- [From(publication date): 0-2024 - May 08, 2025]
- Breakdown by view type
- HTML page views: 246
- PDF downloads: 191
